Source:http://linkedlifedata.com/resource/pubmed/id/15004192
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2004-3-8
|
pubmed:abstractText |
Leukocyte recruitment in response to inflammatory signals is in part governed by interactions between endothelial cell receptors belonging to the Ig superfamily and leukocyte integrins. In our previous work, the human Ig superfamily glycoprotein Thy-1 (CD90) was identified as an activation-associated cell adhesion molecule on human dermal microvascular endothelial cells. Furthermore, the interaction of Thy-1 with a corresponding ligand on monocytes and polymorphonuclear cells was shown to be involved in the adhesion of these leukocytes to activated Thy-1-expressing endothelial cells. In this study, we have identified the specific interaction between human Thy-1 and the leukocyte integrin Mac-1 (CD11b/CD18; alphaMbeta2) both in cellular systems and in purified form. Monocytes and polymorphonuclear cells were shown to adhere to transfectants expressing human Thy-1 as well as to primary Thy-1-expressing human dermal microvascular endothelial cells. Furthermore, leukocyte adhesion to activated endothelium as well as the subsequent transendothelial migration was mediated by the interaction between Thy-1 and Mac-1. This additional pathway in leukocyte-endothelium interaction may play an important role in the regulation of leukocyte recruitment to sites of inflammation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD11b,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD18,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Thy-1,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Macrophage-1 Antigen
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
172
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3850-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15004192-Antigens, CD11b,
pubmed-meshheading:15004192-Antigens, CD18,
pubmed-meshheading:15004192-Antigens, Thy-1,
pubmed-meshheading:15004192-Cell Adhesion,
pubmed-meshheading:15004192-Cell Line,
pubmed-meshheading:15004192-Cell Movement,
pubmed-meshheading:15004192-Cells, Cultured,
pubmed-meshheading:15004192-Endothelium, Vascular,
pubmed-meshheading:15004192-Humans,
pubmed-meshheading:15004192-Inflammation,
pubmed-meshheading:15004192-Leukocytes, Mononuclear,
pubmed-meshheading:15004192-Ligands,
pubmed-meshheading:15004192-Macrophage-1 Antigen,
pubmed-meshheading:15004192-Monocytes,
pubmed-meshheading:15004192-Skin,
pubmed-meshheading:15004192-Transfection
|
pubmed:year |
2004
|
pubmed:articleTitle |
Human Thy-1 (CD90) on activated endothelial cells is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18).
|
pubmed:affiliation |
Department of Dermatology, University of Leipzig, Leipzig, Germany. wetzel.a@gmx.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|